Khiron Life Sciences Reports 2021 Fiscal Year End Results

2021 total revenue increased over 60% YoY to $12.8 million compared to the previous yearCorporation's medical cannabis sales in 2021 increased to ...

Related Keywords

Mexico ,Germany ,Rio De Janeiro ,Estado Do Rio ,Brazil ,United States ,United Kingdom ,Uruguay ,Colombia ,Peru ,Canada ,Toronto ,Ontario ,Peruvian ,America ,Canadian ,Alvaro Torres ,International Financial Reporting Standards ,Corporation Webcast Details ,Linkedin ,Corporation Year End ,Health Services ,Group Khiron Life Sciences Corp ,Khiron Life Sciences Corp ,Regulation Services Provider ,Life Sciences ,Latin America ,Life Sciences Corp ,Key Financial Results ,Medical Cannabis ,Chief Executive Officer ,Year End ,Fourth Quarter ,Call Date ,Khiron Life Sciences ,Although Khiron ,Annual Information Form ,